TY - JOUR
T1 - Automatic measurement of kidney and liver volumes from MR images of patients affected by autosomal dominant polycystic kidney disease
AU - van Gastel, Maatje D.A.
AU - Edwards, Marie E.
AU - Torres, Vicente E.
AU - Erickson, Bradley J.
AU - Gansevoort, Ron T.
AU - Kline, Timothy L.
N1 - Funding Information:
This work was supported in part by the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Center and National Institute of Diabetes and Digestive and Kidney Diseases grants P30DK090728 and K01DK110136 as well as PKD Foundation grant 206g16a. The DIPAK Consortium is sponsored by Dutch Kidney Foundation grants CP10.12 and CP15.01 and Dutch Government grant LSHM15018.
Publisher Copyright:
© 2019 by the American Society of Nephrology.
PY - 2019/8
Y1 - 2019/8
N2 - Background The formation and growth of cysts in kidneys, and often liver, in autosomal dominant polycystic kidney disease (ADPKD) cause progressive increases in total kidney volume (TKV) and liver volume (TLV). Laborious and time-consuming manual tracing of kidneys and liver is the current gold standard. We developed a fully automated segmentation method for TKV and TLV measurement that uses a deep learning network optimized to perform semantic segmentation of kidneys and liver.Methods We used 80% of a set of 440 abdominal magnetic resonance images (T2-weighted HASTE co-ronal sequences) from patients with ADPKD to train the network and the remaining 20% for validation. Both kidneys and liver were also segmented manually. To evaluate the method’s performance, we used an additional test set of images from 100 patients, 45 of whom were also involved in longitudinal analyses.Results TKV and TLV measured by the automated approach correlated highly with manually traced TKV and TLV (intraclass correlation coefficients, 0.998 and 0.996, respectively), with low bias and high precision (<0.1%±2.7% for TKV and-1.6%±3.1% for TLV); this was comparable with inter-reader variability of manual tracing (<0.1%±3.5% for TKV and-1.5%±4.8% for TLV). For longitudinal analysis, bias and precision were <0.1%±3.2% for TKV and 1.4%±2.9% for TLV growth.Conclusions These findings demonstrate a fully automated segmentation method that measures TKV, TLV, and changes in these parameters as accurately as manual tracing. This technique may facilitate future studies in which automated and reproducible TKV and TLV measurements are needed to assess disease severity, disease progression, and treatment response.
AB - Background The formation and growth of cysts in kidneys, and often liver, in autosomal dominant polycystic kidney disease (ADPKD) cause progressive increases in total kidney volume (TKV) and liver volume (TLV). Laborious and time-consuming manual tracing of kidneys and liver is the current gold standard. We developed a fully automated segmentation method for TKV and TLV measurement that uses a deep learning network optimized to perform semantic segmentation of kidneys and liver.Methods We used 80% of a set of 440 abdominal magnetic resonance images (T2-weighted HASTE co-ronal sequences) from patients with ADPKD to train the network and the remaining 20% for validation. Both kidneys and liver were also segmented manually. To evaluate the method’s performance, we used an additional test set of images from 100 patients, 45 of whom were also involved in longitudinal analyses.Results TKV and TLV measured by the automated approach correlated highly with manually traced TKV and TLV (intraclass correlation coefficients, 0.998 and 0.996, respectively), with low bias and high precision (<0.1%±2.7% for TKV and-1.6%±3.1% for TLV); this was comparable with inter-reader variability of manual tracing (<0.1%±3.5% for TKV and-1.5%±4.8% for TLV). For longitudinal analysis, bias and precision were <0.1%±3.2% for TKV and 1.4%±2.9% for TLV growth.Conclusions These findings demonstrate a fully automated segmentation method that measures TKV, TLV, and changes in these parameters as accurately as manual tracing. This technique may facilitate future studies in which automated and reproducible TKV and TLV measurements are needed to assess disease severity, disease progression, and treatment response.
UR - http://www.scopus.com/inward/record.url?scp=85070850763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070850763&partnerID=8YFLogxK
U2 - 10.1681/ASN.2018090902
DO - 10.1681/ASN.2018090902
M3 - Article
C2 - 31270136
AN - SCOPUS:85070850763
SN - 1046-6673
VL - 30
SP - 1514
EP - 1522
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
IS - 8
ER -